Tag Archives: Allergan

Healthcare Sector Roundup: Covance (NYSE:CVD), Merck (NYSE:MRK) – CVD, MRK, PFE, AGN, ASTX, REGN

Healthcare sector finished lower on Tuesday’s trading session and sector tumbled -1.13%. If we consider at the best movers of the sector so Allergan, Inc (NYSE:AGN) and Astex Pharmaceuticals, Inc (NASDAQ:ASTX) were major percentage decliners while key percentage gainer was …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , | Comments Off

Zogenix (NASDAQ:ZGNX) Post Smaller Loss in Fiscal Q4; Ends Marketing Partnership – ZGNX, AGN, ENDP, ALKS

The SAN DIEGO, California based Zogenix, Inc (NASDAQ:ZGNX) announced on Friday that it had a smaller loss in fiscal Q4 after it finished a marketing partnership on its injectable migraine treatment, Sumavel DosePro.

Zogenix ended a marketing partnership with Japanese …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , | Comments Off

Volume Gainers Watch List: XOMA (NASDAQ:XOMA), Spectrum Pharmaceuticals (NASDAQ:SPPI) – XOMA, SPPI, AGN, BIOS, DVAX, XNPT

Tuesday’s trading session data confirmed that healthcare sector reacted positively and the major percentage gainer in sectors. BioScrip Inc (NASDAQ:BIOS) and Dynavax Technologies Corporation (NASDAQ:DVAX) were major percentage gainer in this sector while key percentage decliner was XenoPort, Inc (NASDAQ:XNPT).…

Posted in Latest Headlines, Services | Tagged , , , , , , , , , , , , , , , , | Comments Off

Pernix Therapeutics (NYSE:PTX) To Acquire Somaxon (SOMX); $25 Million Accord – PTX, CRME, DEPO, AGN, DVAX, AMRN, ALXA, PFE, JNJ

Pernix Therapeutics Holdings Inc (NYSE:PTX) reported on Tuesday that it is purchasing Somaxon Pharmaceuticals, Inc (NASDAQ:SOMX) in a stock-for-stock agreement, worth at $25 million.

The Woodlands, Texas based Pernix anticipates to benefit from Somaxon’s insomnia drug Silenor in the purchase, …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off

MAP Pharmaceuticals (NASDAQ:MAPP) Wins FDA Approval for Levadex; Stock Hikes – MAPP, AGN, PATH, ZGNX

The Mountain View, California based MAP Pharmaceuticals Inc’s (NASDAQ:MAPP) stock hiked on Friday after encouraging regulatory news on what could become the corporation’s primary approved product.

MAP reported that the United States Food and Drug Administration permitted the drug developer’s …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , | Comments Off

Allergan, Inc. (NYS: AGN) Hits Deal to Obtain Skin Care Business from SkinMedica – AGN, NVS, JNJ, VRX

Allergan, Inc. (NYS: AGN)declares that it has moved into a decisive deal with SkinMedica, Inc. to pbtainthe privately held firm’s topical aesthetics skin care unit.

According to the terms of the deal, Allergan would pay SkinMedica $350 million directly (subject …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , | Comments Off